Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

October 29, 2026

Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales. Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.

Restaurant Brands reports mixed results as Burger King’s U.S. turnaround shows signs of success

U.S. worker job engagement hits lowest level since 2011, new Gallup poll finds

admin http://arzu159951-010-site2.ntempurl.com

Latest Articles

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Related Articles

Family offices can save millions with this tax strategy but it can strain family ties

Kalshi valuation jumps to $40 billion in latest funding round

Warren urges DOJ criminal probe of Bank of America over anti-money-laundering violations

Latest Articles

Family offices can save millions with this tax strategy but it can strain family ties

Kalshi valuation jumps to $40 billion in latest funding round

Warren urges DOJ criminal probe of Bank of America over anti-money-laundering violations

AI build-out hits snag as Google and Microsoft put off raising capex forecasts

Up 100% in one year! Infra stock jumps 10% after Q2 results 2026 | Will the rally continue? Target, stop-loss